Unique Ingredient Identifier 7FLD91C86K is listed as a ingredient substance
| RN | 6381-92-6 |
| NCIT | C61741 |
| RXCUI | 1310470 |
| MF | C10H12N2O8.2Na.2H.2H2O |
| INCHI KEY | OVBJJZOQPCKUOR-UHFFFAOYSA-L |
| SMILES | [H+].[H+].O.O.[Na+].[Na+].[O-]C(=O)CN(CCN(CC([O-])=O)CC([O-])=O)CC([O-])=O |
UNII 7FLD91C86K EDETATE DISODIUM is commonly included in medications in the following forms.
| Route | Dosage Form | Potency |
|---|---|---|
| AN,INFILTRATION | INJECTION | 0.011 % |
| AN,INFILTRATION | SOLUTION, INJECTION | NA |
| AURICULAR (OTIC) | SOLUTION | 0.1 % |
| AURICULAR (OTIC) | SUSPENSION | NA |
| CAUDAL BLOCK | INJECTION | NA |
| EPIDURAL | INJECTION | 0.011 % |
| IM - IV | INJECTABLE | 0.05 % |
| IM - IV | INJECTION | 0.5 MG/1ML |
| IM - IV | INJECTION | 0.05 % |
| IM - IV | LIQUID, WATER, STERILE, FOR INJECTION | 0.01 % |
| IM - IV | SOLUTION, INJECTION | 0.05 % |
| IM - IV - SC | INJECTION | 0.2 % |
| IM - SC | INJECTION | 0.2 % |
| INHALATION | SOLUTION | 0.1 mg/3mL |
| INHALATION | SOLUTION | 0.05 %W/V |
| INHALATION | SOLUTION, FOR INHALATION | 0.005 % |
| INHALATION | SUSPENSION | 0.19 mg/2mL |
| INHALATION | SUSPENSION, FOR INHALATION | 0.01 % |
| INTRA-ARTERIAL | INJECTION | NA |
| INTRA-ARTICULAR | INJECTABLE | 0.01 % |
| INTRA-ARTICULAR | INJECTION | 0.05 % |
| INTRA-ARTICULAR | INJECTION, SUSTAINED ACTION | NA |
| INTRABURSAL | INJECTION | 0.01 % |
| INTRACARDIAC | INJECTION | 0.2 mg/1mL |
| INTRACARDIAC | INJECTION | NA |
| INTRACAVITARY | INJECTION | NA |
| INTRADERMAL | INJECTION | NA |
| INTRADERMAL | INJECTION, SUSTAINED ACTION | NA |
| INTRADISCAL | POWDER, FOR INJECTION SOLUTION | NA |
| INTRALESIONAL | INJECTABLE | 0.01 % |
| INTRALESIONAL | INJECTION | 0.05 % |
| INTRALESIONAL | INJECTION, SUSTAINED ACTION | NA |
| INTRAMUSCULAR | INJECTABLE | 0.01 %W/V |
| INTRAMUSCULAR | INJECTION | 10 %W/V |
| INTRAMUSCULAR | INJECTION | 0.2 mg/1mL |
| INTRAMUSCULAR | INJECTION, SOLUTION | 0.02 % |
| INTRAMUSCULAR | INJECTION, SUSTAINED ACTION | NA |
| INTRAMUSCULAR | SOLUTION, INJECTION | 0.1 %W/V |
| INTRASYNOVIAL | INJECTION | NA |
| INTRASYNOVIAL | INJECTION, SUSTAINED ACTION | NA |
| INTRAUTERINE | SOLUTION | NA |
| INTRAVASCULAR | INJECTION | 0.04 % |
| INTRAVENOUS | EMULSION, INJECTION | 0.005 % |
| INTRAVENOUS | INFUSION | 0.01 % |
| INTRAVENOUS | INJECTABLE | 1.1 mg/mL |
| INTRAVENOUS | INJECTABLE | 0.01 % |
| INTRAVENOUS | INJECTION | 10 % |
| INTRAVENOUS | INJECTION | 0.5 MG/1ML |
| INTRAVENOUS | INJECTION, SOLUTION | 0.25 MG/1ML |
| INTRAVENOUS | LIQUID, WATER, STERILE, FOR INJECTION | 0.5 MG/1ML |
| INTRAVENOUS | LIQUID, WATER, STERILE, FOR INJECTION | 0.01 % |
| INTRAVENOUS | POWDER, FOR INJECTION SOLUTION | 0.32 MG/1ML |
| INTRAVENOUS | POWDER, FOR INJECTION SOLUTION | 0.1 % |
| INTRAVENOUS | POWDER, FOR INJECTION SOLUTION, LYOPHILIZED | 1.88 % |
| INTRAVENOUS | POWDER, FOR INJECTION SOLUTION, LYOPHILIZED | 0.5 MG/ML |
| INTRAVENOUS | SOLUTION | 0.05 % |
| INTRAVENOUS | SOLUTION, INJECTION | 0.11 % |
| IONTOPHORESIS | PATCH, CONTROLLED RELEASE | 0.1 MG |
| IV - SC | SOLUTION, INJECTION | 0.02 % |
| IV(INFUSION) | EMULSION, INJECTION | 0.05 % |
| IV(INFUSION) | INJECTABLE | 0.02 % |
| IV(INFUSION) | INJECTION | 1 % |
| IV(INFUSION) | POWDER, FOR INJECTION SOLUTION, LYOPHILIZED | 1.88 % |
| IV(INFUSION) | POWDER, FOR INJECTION SUSPENSION, LYOPHILIZED | 0.04 % |
| IV(INFUSION) | SOLUTION, INJECTION | 0.04 % |
| NASAL | SOLUTION | 0.1 % |
| NASAL | SOLUTION, SPRAY | 0.05 % |
| NASAL | SOLUTION, SPRAY, METERED, PUMP | 0.007 % |
| NASAL | SPRAY | 106 UG/SPRAY |
| NASAL | SPRAY | 0.1 % |
| NASAL | SPRAY, METERED | 68.5 MCG/SPRAY |
| NASAL | SPRAY, METERED | 0.5 % |
| NERVE BLOCK | INJECTION | 0.011 % |
| NERVE BLOCK | SOLUTION, INJECTION | NA |
| OPHTHALMIC | DROPS | 0.05 % |
| OPHTHALMIC | EMULSION | 0.3 %W/V |
| OPHTHALMIC | GEL | 0.055 % |
| OPHTHALMIC | SOLUTION | 1.27 MG/1ML |
| OPHTHALMIC | SOLUTION | 0.5 % |
| OPHTHALMIC | SOLUTION, DROPS | 0.15 mg/1mL |
| OPHTHALMIC | SOLUTION, DROPS | 0.1 % |
| OPHTHALMIC | SOLUTION, DROPS | 0.01 %W/V |
| OPHTHALMIC | SOLUTION/ DROPS | 0.1 MG/1ML |
| OPHTHALMIC | SOLUTION/DROPS | 0.015 % |
| OPHTHALMIC | SUSPENSION | 0.13 % |
| OPHTHALMIC | SUSPENSION, DROPS | 0.1 % |
| ORAL | CAPSULE | 1 MG |
| ORAL | CAPSULE (IMMED./COMP. RELEASE) | 1 MG |
| ORAL | CAPSULE, SOFT GELATIN | 1 MG |
| ORAL | CONCENTRATE | 3 MG/1ML |
| ORAL | EMULSION | NA |
| ORAL | LIQUID | 0.5 MG/1ML |
| ORAL | POWDER, FOR SOLUTION | NA |
| ORAL | POWDER, FOR SUSPENSION | 3 MG/5ML |
| ORAL | SOLUTION | 210 MG/160ML |
| ORAL | SOLUTION | 5.53 MG/5ML |
| ORAL | SOLUTION | 2.5 mg/5 mL |
| ORAL | SOLUTION, ELIXIR | 0.005 % |
| ORAL | SOLUTION, FOR INHALATION | 0.055 MG/.5ML |
| ORAL | SOLUTION/DROPS | 0.1 %W/V |
| ORAL | SUSPENSION | 7.5 MG/5ML |
| ORAL | SUSPENSION, DROPS | 1 MG/2.5ML |
| ORAL | SUSPENSION, EXTENDED RELEASE | 10 MG/5ML |
| ORAL | SUSPENSION, FOR INHALATION | 0.2 MG/2ML |
| ORAL | SUSPENSION, SYRUP, SUSTAINED ACTION | 0.01 % |
| ORAL | SYRUP | 25 MG/5ML |
| ORAL | TABLET | 4 MG |
| ORAL | TABLET | 0.2 ug |
| ORAL | TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE | 0.25 MG |
| ORAL | TABLET, COATED | 0.21 MG |
| ORAL | TABLET, DELAYED ACTION | 100 MG |
| ORAL | TABLET, DELAYED ACTION, ENTERIC COATED | 100 MG |
| ORAL | TABLET, EFFERVESCENT, FOR SOLUTION | 0.9 MG |
| ORAL | TABLET, EXTENDED RELEASE | 5 MG |
| ORAL | TABLET, FILM COATED | 4 MG |
| ORAL | TABLET, ORALLY DISINTEGRATING | 3 MG |
| OTIC | SUSPENSION | 0.01 % |
| RECTAL | EMULSION, AEROSOL FOAM | 0.085 % |
| RECTAL | ENEMA | 0.1 % |
| RECTAL | SOLUTION | 0.04 % |
| RESPIRATORY (INHALATION) | INHALANT | 0.011 % |
| RESPIRATORY (INHALATION) | SOLUTION | 0.05 % |
| RESPIRATORY (INHALATION) | SOLUTION, FOR INHALATION | 0.03 % |
| RESPIRATORY (INHALATION) | SPRAY | 0.05 % |
| RESPIRATORY (INHALATION) | SUSPENSION, FOR INHALATION | 0.02 % |
| SOFT TISSUE | INJECTION | 0.05 % |
| SUBCUTANEOUS | INJECTABLE | 0.1 % |
| SUBCUTANEOUS | INJECTION | 0.2 % |
| SUBCUTANEOUS | INJECTION | 0.2 mg/1mL |
| SUBCUTANEOUS | INJECTION, SOLUTION | 0.02 % |
| SUBCUTANEOUS | SOLUTION, INJECTION | 0.11 % |
| TOPICAL | CREAM | 0.05 %W/W |
| TOPICAL | CREAM, AUGMENTED | 0.1 %W/W |
| TOPICAL | CREAM, EMULSION, SUSTAINED RELEASE | 0.05 %W/W |
| TOPICAL | DROPS | 0.05 %W/V |
| TOPICAL | EMULSION | 0.11 %W/W |
| TOPICAL | EMULSION, AEROSOL FOAM | 0.05 %W/W |
| TOPICAL | EMULSION, CREAM | 0.1 %W/W |
| TOPICAL | FILM, CONTROLLED RELEASE | 14 MG |
| TOPICAL | GEL | 0.17 %W/W |
| TOPICAL | LOTION | 0.12 %W/V |
| TOPICAL | LOTION | 0.05 %W/W |
| TOPICAL | OINTMENT | 0.007 %W/W |
| TOPICAL | OPHTHALMIC SUSPENSION DOSAGE FORM | 0.06 %W/V |
| TOPICAL | PATCH | 7 MG |
| TOPICAL | PATCH, CONTROLLED RELEASE | NA |
| TOPICAL | POWDER, FOR SOLUTION | NA |
| TOPICAL | SOLUTION | 1.27 MG/1ML |
| TOPICAL | SOLUTION | 0.1 %W/W |
| TOPICAL | SOLUTION, DROPS | 0.05 %W/V |
| TOPICAL | SOLUTION/DROPS | 0.01 %W/V |
| TOPICAL | SUSPENSION | NA |
| TOPICAL | SUSPENSION, DROPS | 0.1 %W/W |
| TRANSDERMAL | GEL | 0.06 % |
| URETERAL | SOLUTION | NA |
| URETHRAL | SOLUTION | NA |
| VAGINAL | CREAM | 0.05 %W/W |
| VAGINAL | CREAM, EMULSION, SUSTAINED RELEASE | 0.05 % |
| VAGINAL | EMULSION, CREAM | 0.05 % |
| VAGINAL | GEL | 0.05 % |